Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000892425 | SCV001036297 | benign | not provided | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000892425 | SCV003916367 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | IL2RB: BP4, BS2 |
Breakthrough Genomics, |
RCV000892425 | SCV005277239 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000892425 | SCV001929545 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000892425 | SCV001972931 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003920782 | SCV004729757 | benign | IL2RB-related disorder | 2019-11-26 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |